Lymphocytes regulate expression of the SARS‐CoV‐2 cell entry factor ACE2 in the pancreas of T2DM patients
- 11 April 2023
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 40 (10)
Abstract
Aims: COVID‐19 patients with type 2 diabetes mellitus (T2DM) show both poorer clinical outcomes and have an increased risk of death. SARS‐CoV‐2 virus infection requires simultaneous expression of the SARS‐CoV‐2 cell entry factors angiotensin‐converting enzyme 2 (ACE2) and transmembrane protease serine type 2 (TMPRSS2) in the same cell. The aim of the study was to explore the underlying mechanisms of a COVID‐19 infection in patients with T2DM.Methods: The distribution and expression of AEC2 and TMPRSS2 in different pancreatic cell types in clinical samples of T2DM patients and diabetic mouse models were analysed by single‐cell sequencing, bioinformatics analysis and basic experiments.Results: The results showed that ACE2 and TMPRSS2 are expressed in the ducts of the human pancreas. These findings suggest that SARS‐CoV‐2 can infect ductal cells in vivo through ACE2 and TMPRSS2. T2DM can promote the co‐expression of ACE2 and TMPRSS2 in exocrine ducts, including in the human pancreas. We hypothesize that ACE2 expression levels are associated with increased numbers of lymphocytes in vivo.Conclusions: Increased blood glucose levels are associated with increased ACE2 expression and an increased number of lymphocytes. At the same time, lymphocytes can promote ACE2 expression.Keywords
Funding Information
- National Natural Science Foundation of China (82003108, 81960662, 82200550)
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20210324132407019, LGKCYLWS2022002)
This publication has 27 references indexed in Scilit:
- Viral infiltration of pancreatic islets in patients with COVID-19Nature Communications, 2021
- SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β CellsCell Metabolism, 2020
- Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19Cell Metabolism, 2020
- Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidenceDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19Biomedicine & Pharmacotherapy, 2020
- Metformin and COVID-19: From cellular mechanisms to reduced mortalityDiabetes & Metabolism, 2020
- Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deteriorationDiabetes Research and Clinical Practice, 2020
- A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and OrganoidsCell Stem Cell, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expressionJournal of Cell Communication and Signaling, 2018